Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT05314426
The purpose of this study is to help scientists and clinicians discover answers to research questions related to antibiotic-resistant bacterial infections, and the role that phage therapy plays as a possible treatment.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Rochester, Minnesota, 55905, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 years
To recruit and enroll participants up to 100 participants who have received or will receive phage therapy treatment
Time frame: 5 years
Total number of biospecimens collected which may include blood samples and synovial fluid
Time frame: 5 years
Review the medical record of enrolled participants to ascertain any new health outcomes.
Time frame: 5 years
Total number of collaborations with clinical investigators and researchers at both Mayo Clinic and across the globe.
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07619924
Bacteriophage Therapy, Infections
Xi'an, Shaanxi, China
View Trial DetailsNCT07461337
Bacteriophage Therapy, Prosthetic Joint Infections of Hip
Calgary, Canada
View Trial DetailsNCT07429162
Actinomycetales Infections, Bacterial Infections
View Trial Details